Compounds > deoxycytidine

deoxycytidine and Arterial Occlusive Diseases

deoxycytidine has been researched along with Arterial Occlusive Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, F; Qi, WX; Shen, Z; Sun, YJ; Tang, LN; Yao, Y1
Demeaux, H; Dilhuydy, MS; Faure, I; Leng, B; Mercié, P; Pellegrin, JL; Viallard, JF1

Reviews

1 review(s) available for deoxycytidine and Arterial Occlusive Diseases

ArticleYear
Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis.
    British journal of clinical pharmacology, 2013, Volume: 76, Issue:3

    Topics: Antimetabolites, Antineoplastic; Arterial Occlusive Diseases; Deoxycytidine; Gemcitabine; Humans; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Risk; Venous Thromboembolism

2013

Other Studies

1 other study(ies) available for deoxycytidine and Arterial Occlusive Diseases

ArticleYear
[Splenic vascular occlusion in the course of pancreatic cancer].
    La Revue de medecine interne, 2000, Volume: 21, Issue:7

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Arterial Occlusive Diseases; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans; Infarction; Middle Aged; Pancreatic Neoplasms; Spleen; Tomography, X-Ray Computed

2000